NASDAQ: REAXReal Remax Group Inc Stock
$19.81-0.47 (-2.32%)
Updated Sep 14, 2026
REAX Price
$19.81
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$17.76
52 Week High
$28.85
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-14.74
Operating Cash Flow
N/A
Beta
2.27
Next Earnings
Oct 29, 2026
Ex-Dividend
N/A
Next Dividend
N/A
REAX Overview
Operating with its various subsidiaries, The Real Brokerage Inc. functions as a technology-driven real estate brokerage enterprise. The company delivers comprehensive real estate agency solutions through an expansive network of agents. It equips its agents with a cutting-edge, mobile-optimized technological platform for managing their business activities, alongside offering favorable contractual terms and avenues for generating wealth. Its operations span 42 states across the United States, the District of Columbia, and Canada. The Real Brokerage Inc.'s corporate headquarters are located in Toronto, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine REAX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Real Estate Service
Industry Rating
B
REAX
Ranked#15 of 24
Ranked#15 of 24
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $343.55 | A | |
| $19.21 | A | |
| $30.96 | B |
Be the first to know about important REAX news, forecast changes, insider trades & much more!
REAX News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how REAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
REAX's short-term liabilities ($148.24M) exceed its short-term assets ($8.40M)
Short-term Liabilities Financials
REAX's long-term liabilities ($465.76M) exceed its short-term assets ($8.40M)
Long-term Liabilities Financials
REAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more REAX due diligence checks available for Premium users.
Valuation
REAX's financial health
Profit margin
Revenue
$70.2M
Net Income
$0.0
Profit Margin
0%
Assets to liabilities
Assets
$572.3M
Liabilities
$614.0M
Debt to equity
-14.74
REAX's short-term liabilities ($148.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
REAX's long-term liabilities ($465.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
REAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
REAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
Real Remax Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.